The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Exacerbations of chronic obstructive pulmonary disease
Open accessAbstract
Exacerbations of chronic obstructive pulmonary disease are of major importance in terms of their prolonged detrimental effects on patients, the acceleration in disease progression and high healthcare costs. There is still debate about how exacerbations should be defined and graded, and their mechanisms are poorly understood. The major causal agents are either bacteria or viral infections, or a combination of the two. Noninfective causes include air pollution and pulmonary embolus but, in some patients, no cause is identified. Exacerbations represent an increase in the inflammation that is present in the stable state, with increased numbers of inflammatory cells (particularly neutrophils), cytokines, chemokines and proteases in the airways, and increased concentrations of certain cytokines and C-reactive protein in the blood. There are presently no reliable biomarkers with which to predict exacerbations. Exacerbations have a long-lasting adverse influence on health status. High doses of bronchodilators are the mainstay of treatment and systemic corticosteroids have some benefit. The routine use of antibiotics remains controversial but they are of benefit with exacerbations of a bacterial origin. Noninvasive ventilation is beneficial in preventing the need for intubation and its important complications but it is not certain whether its use in stable patients prevents exacerbations. Although important advances have been made, more effective treatments are needed in the future for prevention and treatment of exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
Connors, A. F., Dawson, N. V., Thomas, C., Harrell, F. E., Desbiens, N., Fulkerson, W. J., Kussin, P., Bellamy, P., Goldman, L., & Knaus, W. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887592 · Cited by 1,393
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., & Vallance, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041747 · Cited by 1,375
Exhaled breath condensate: methodological recommendations and unresolved questions
Horváth, I., Hunt, J., & Barnes, P. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00029705 · Cited by 1,284
Self-citationPlant, P., Owen, J., & Elliott, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02323-0 · Cited by 1,242
Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Toward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Self-citationR�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Exhaled Markers of Pulmonary Disease
KHARITONOV, S. A., & BARNES, P. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2009041 · Cited by 844
Self-citationLightowler, J. V., Wedzicha, J. A., Elliott, M. W., & Ram, F. S. F. (2003) · BMJ · doi:10.1136/bmj.326.7382.185 · Cited by 843
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
(2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.ats1000 · Cited by 790
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Vincken, W., van Noord, J. A., Greefhorst, A. P. M., Bantje, T. A., Kesten, S., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238702 · Cited by 736
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Calverley, P. M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00027003 · Cited by 730
Patel, I. S. (2002) · Thorax · doi:10.1136/thorax.57.9.759 · Cited by 690
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Geographic Variations in Prevalence and Underdiagnosis of COPD
Penña, V. S., Miravitlles, M., Gabriel, R., Jiménez-Ruiz, C. A., Villasante, C., Masa, J. F., Viejo, J. L., & Fernández-Fau, L. (2000) · Chest · doi:10.1378/chest.118.4.981 · Cited by 659
Davies, L., Angus, R., & Calverley, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11326-0 · Cited by 595
Brightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Barnes, P. J., Adcock, I. M., & Ito, K. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00117504 · Cited by 564
Self-citationAirway eosinophilia in chronic bronchitis during exacerbations.
Saetta, M., Di Stefano, A., Maestrelli, P., Turato, G., Ruggieri, M. P., Roggeri, A., Calcagni, P., Mapp, C. E., Ciaccia, A., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952628 · Cited by 536
Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD
Stockley, R. A., O’Brien, C., Pye, A., & Hill, S. L. (2000) · Chest · doi:10.1378/chest.117.6.1638 · Cited by 535
Rohde, G. (2003) · Thorax · doi:10.1136/thorax.58.1.37 · Cited by 524
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Dekhuijzen, P. N., Aben, K. K., Dekker, I., Aarts, L. P., Wielders, P. L., van Herwaarden, C. L., & Bast, A. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.154.3.8810624 · Cited by 503
Rabe, K. F., Bateman, E. D., O'Donnell, D., Witte, S., Bredenbröker, D., & Bethke, T. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67100-0 · Cited by 475
AARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Impact of preventing exacerbations on deterioration of health status in COPD
Spencer, S., Calverley, P. M. A., Burge, P. S., & Jones, P. W. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00121404 · Cited by 441
Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440
Niewoehner, D. E., Rice, K., Cote, C., Paulson, D., Cooper, J. A. D., Korducki, L., Cassino, C., & Kesten, S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00007 · Cited by 436
Anderson, H., Spix, C., Medina, S., Schouten, J., Castellsague, J., Rossi, G., Zmirou, D., Touloumi, G., Wojtyniak, B., Ponka, A., et al. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051064 · Cited by 424
Hill, A. T., Campbell, E. J., Hill, S. L., Bayley, D. L., & Stockley, R. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00507-6 · Cited by 414
Barnes, P. J., Ito, K., & Adcock, I. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15650-x · Cited by 399
Self-citationRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000058687.18516.14 · Cited by 390
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
Confalonieri, M., Garuti, G., Cattaruzza, M. S., Osborn, J. F., Antonelli, M., Conti, G., Kodric, M., Resta, O., Marchese, S., Gregoretti, C., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00085304 · Cited by 378
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Sethi, S., Maloney, J., Grove, L., Wrona, C., & Berenson, C. S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1525oc · Cited by 373
Conti, G., Antonelli, M., Navalesi, P., Rocco, M., Bufi, M., Spadetta, G., & Meduri, G. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1478-0 · Cited by 371
Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations: A Meta-analysis
Saint, S. (1995) · JAMA · doi:10.1001/jama.1995.03520360071042 · Cited by 365
Qiu, Y., Zhu, J., Bandi, V., Atmar, R. L., Hattotuwa, K., Guntupalli, K. K., & Jeffery, P. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-794oc · Cited by 351
Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
Aaron, S. D., Vandemheen, K. L., Hebert, P., Dales, R., Stiell, I. G., Ahuja, J., Dickinson, G., Brison, R., Rowe, B. H., Dreyer, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023161 · Cited by 350
Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Lacy, P., York, E., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 347
Papi, A., & Johnston, S. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9707 · Cited by 344
Miravitlles, M., Guerrero, T., Mayordomo, C., Sánchez-Agudo, L., Nicolau, F., & Segú, J. L. (2000) · Respiration · doi:10.1159/000067462 · Cited by 335
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease
Seemungal, T. A. R., Harper-Owen, R., Bhowmik, A., Jeffries, D. J., & Wedzicha, J. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d19.x · Cited by 334
TAKABATAKE, N., NAKAMURA, H., ABE, S., INOUE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., & TOMOIKE, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9903022 · Cited by 327
Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease
MAZIAK, W., LOUKIDES, S., CULPITT, S., SULLIVAN, P., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.97-05009 · Cited by 324
Self-citationWilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2006) · Chest · doi:10.1378/chest.129.2.317 · Cited by 317
Tillie-Leblond, I., Marquette, C.-H., Perez, T., Scherpereel, A., Zanetti, C., Tonnel, A.-B., & Remy-Jardin, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00005 · Cited by 312
Plant, P. K. (2001) · Thorax · doi:10.1136/thorax.56.9.708 · Cited by 310
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
Sin, D. D. (2005) · Thorax · doi:10.1136/thx.2005.045385 · Cited by 307
SIN, D. D., & TU, J. V. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2009033 · Cited by 305
Wouters, E. F. M., Creutzberg, E. C., & Schols, A. M. W. J. (2002) · Chest · doi:10.1378/chest.121.5_suppl.127s · Cited by 301
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., & Saetta, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1659pp · Cited by 298
Self-citationGARCIA-AYMERICH, J., MONSÓ, E., MARRADES, R. M., ESCARRABILL, J., FÉLEZ, M. A., SUNYER, J., ANTÓ, J. M., & the EFRAM Investigators (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2006012 · Cited by 297
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Gompertz, S., O'Brien, C., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99114901 · Cited by 292
Heart Failure and cHronic Obstructive Pulmonary Disease: An Ignored Combination?
Rutten, F. H., Cramer, M.-J. M., Lammers, J.-W. J., Grobbee, D. E., & Hoes, A. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.010 · Cited by 291
Pharmacoeconomic Evaluation of COPD
Hilleman, D. E., Dewan, N., Malesker, M., & Friedman, M. (2000) · Chest · doi:10.1378/chest.118.5.1278 · Cited by 288
Short term variations in hospital admissions and mortality and particulate air pollution.
Wordley, J., Walters, S., & Ayres, J. G. (1997) · Occupational and Environmental Medicine · doi:10.1136/oem.54.2.108 · Cited by 286
Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD
Miravitlles, M., Murio, C., Guerrero, T., & Gisbert, R. (2002) · Chest · doi:10.1378/chest.121.5.1449 · Cited by 283
Nouira, S., Marghli, S., Belghith, M., Besbes, L., Elatrous, S., & Abroug, F. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07097-0 · Cited by 282
Biernacki, W. A. (2003) · Thorax · doi:10.1136/thorax.58.4.294 · Cited by 276
Grandjean, E. M., Berthet, P., Ruffmann, R., & Leuenberger, P. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88479-9 · Cited by 270
Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women
Rana, J. S., Mittleman, M. A., Sheikh, J., Hu, F. B., Manson, J. E., Colditz, G. A., Speizer, F. E., Barr, R. G., & Camargo, C. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2478 · Cited by 269
MALTAIS, F., OSTINELLI, J., BOURBEAU, J., TONNEL, A. B., JACQUEMET, N., HADDON, J., ROULEAU, M., BOUKHANA, M., MARTINOT, J. B., & DUROUX, P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.5.2109093 · Cited by 265
RENNARD, S. I., ANDERSON, W., ZuWALLACK, R., BROUGHTON, J., BAILEY, W., FRIEDMAN, M., WISNIEWSKI, M., & RICKARD, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.9903053 · Cited by 265
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Wedzicha, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306030 · Cited by 261
Evans, T. W. (2001) · Intensive Care Medicine · doi:10.1007/s001340000721 · Cited by 252
A Multidimensional Grading System (BODE Index) as Predictor of Hospitalization for COPD
Ong, K.-C., Earnest, A., & Lu, S.-J. (2005) · Chest · doi:10.1378/chest.128.6.3810 · Cited by 251
Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease
Donaldson, G. C., Seemungal, T., Jeffries, D. J., & Wedzicha, J. A. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13d25.x · Cited by 243
Dewan, N. A., Rafique, S., Kanwar, B., Satpathy, H., Ryschon, K., Tillotson, G. S., & Niederman, M. S. (2000) · Chest · doi:10.1378/chest.117.3.662 · Cited by 237
Crooks, S. W., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15b09.x · Cited by 235
Neutrophil Chemotactic Activity of Sputum From Patients With COPD
Beeh, K. M., Kornmann, O., Buhl, R., Culpitt, S. V., Giembycz, M. A., & Barnes, P. J. (2003) · Chest · doi:10.1378/chest.123.4.1240 · Cited by 233
Self-citationThe Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis
HILL, A. T., BAYLEY, D., & STOCKLEY, R. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9901091 · Cited by 230
FEENSTRA, T. L., van GENUGTEN, M. L. L., HOOGENVEEN, R. T., WOUTERS, E. F., & RUTTEN-van MÖLKEN, M. P. M. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2003167 · Cited by 228
Airway Inflammation and Etiology of Acute Exacerbations of Chronic Bronchitis
Sethi, S., Muscarella, K., Evans, N., Klingman, K. L., Grant, B. J. B., & Murphy, T. F. (2000) · Chest · doi:10.1378/chest.118.6.1557 · Cited by 219
Caramori, G. (2003) · Thorax · doi:10.1136/thorax.58.4.348 · Cited by 216
Exhaled nitric oxide from lung periphery is increased in COPD
Brindicci, C., Ito, K., Resta, O., Pride, N. B., Barnes, P. J., & Kharitonov, S. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00125304 · Cited by 206
ZHU, J., QIU, Y. S., MAJUMDAR, S., GAMBLE, E., MATIN, D., TURATO, G., FABBRI, L. M., BARNES, N., SAETTA, M., & JEFFERY, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2007050 · Cited by 203
Gilmour, P. S., Rahman, I., Donaldson, K., & MacNee, W. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00277.2002 · Cited by 203
Wilson, R., Allegra, L., Huchon, G., Izquierdo, J.-L., Jones, P., Schaberg, T., & Sagnier, P.-P. (2004) · Chest · doi:10.1378/chest.125.3.953 · Cited by 198
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Fujimoto, K., Yasuo, M., Urushibata, K., Hanaoka, M., Koizumi, T., & Kubo, K. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00047504 · Cited by 194
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
Roland, M. (2001) · Thorax · doi:10.1136/thorax.56.1.30 · Cited by 194
Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke
Martorana, P. A., Beume, R., Lucattelli, M., Wollin, L., & Lungarella, G. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1549oc · Cited by 194
Prospects for new drugs for chronic obstructive pulmonary disease
Barnes, P. J., & Hansel, T. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17025-6 · Cited by 189
Self-citationPhysiological changes during symptom recovery from moderate exacerbations of COPD
Parker, C. M., Voduc, N., Aaron, S. D., Webb, K. A., & O'Donnell, D. E. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00136304 · Cited by 176
DIAZ, O., IGLESIA, R., FERRER, M., ZAVALA, E., SANTOS, C., WAGNER, P. D., ROCA, J., & RODRIGUEZ-ROISIN, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9701027 · Cited by 175
Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease
Stevenson, N. J., Walker, P. P., Costello, R. W., & Calverley, P. M. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-595oc · Cited by 170
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation
Stockley, R. A., Bayley, D. L., Hill, S. L., Hill, A. T., Crooks, S., & Campbell, E. J. (2001) · Thorax · doi:10.1136/thorax.56.5.366 · Cited by 166
Dentener, M. A. (2001) · Thorax · doi:10.1136/thorax.56.9.721 · Cited by 165
Reduced Histone Deacetylase in COPD
Barnes, P. J. (2006) · Chest · doi:10.1378/chest.129.1.151 · Cited by 161
Self-citationPlant, P. K., Owen, J. L., Parrott, S., & Elliott, M. W. (2003) · BMJ · doi:10.1136/bmj.326.7396.956 · Cited by 159
Alternative Mechanisms for Long-Acting β2-Adrenergic Agonists in COPD
Johnson, M., & Rennard, S. I. (2001) · CHEST Journal · doi:10.1378/chest.120.1.258 · Cited by 156
Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease
Geßner, C., Scheibe, R., Wötzel, M., Hammerschmidt, S., Kühn, H., Engelmann, L., Hoheisel, G. B., Gillissen, A., Sack, U., & Wirtz, H. R. W. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.02.041 · Cited by 156
Wilson, R., Schentag, J. J., Ball, P. D., & Mandell, L. A. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85139-6 · Cited by 151
Rahman, I., Skwarska, E., & MacNee, W. (1997) · Thorax · doi:10.1136/thx.52.6.565 · Cited by 142
Pinto-Plata, V., Livnat, G., Girish, M., Cabral, H., Masdin, P., Linacre, P., Dew, R., Kenney, L., & Celli, B. R. (2007) · CHEST Journal · doi:10.1378/chest.06-0668 · Cited by 141
Self-citationCreutzberg, E. C., Wouters, E. F. �., Augustin, I. M. L., Dentener, M. A., & Schols, A. M. W. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912016 · Cited by 140
Double-Stranded RNA Induces the Synthesis of Specific Chemokines by Bronchial Epithelial Cells
Gern, J. E., French, D. A., Grindle, K. A., Brockman-Schneider, R. A., Konno, S.-I., & Busse, W. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0055oc · Cited by 130
Agustí, A. G. N., Villaverde, J. M. F., & Togores, B. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14c08.x · Cited by 120
Inflammatory markers and the risk of coronary heart disease in men and women
Pai, J. K., Pischon, T., & Ma, J. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.067 · Cited by 120
Rennard, S. I., Schachter, N., Strek, M. E., Rickard, K., & Amit, O. (2006) · CHEST Journal · doi:10.1378/chest.129.1.56 · Cited by 113
Çalıkoğlu, M. E., Şahin, G., Ünlü, A., Öztürk, C., Tamer, L., Ercan, B., Kanık, A., & Atik, U. (2004) · Respiration · doi:10.1159/000075648 · Cited by 107
Treatment of stable chronic obstructive pulmonary disease
Rennard, S. I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16941-9 · Cited by 106
with chronic obstructive pulmonary disease Severe acute exacerbations and mortality in patients
Ochando, R., Soler‐Cataluña, J. J., Martínez‐García, M. Á., Sánchez, P. R., Salcedo, E., & Navarro, M. (2006) · Cited by 103
Gerritsen, W. B., Asin, J., Zanen, P., van den Bosch, J. M. M., & Haas, F. J. L. M. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.04.017 · Cited by 102
JACOBSON, L., Hertzman, P., Löfdahl, C., Skoogh, B., & Lindgren, B. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0733 · Cited by 95
Systemic Glucocorticoids in Severe Exacerbations of COPD
Sayıner, A., Aytemur, Z. A., Cirit, M., et al. (2001) · CHEST Journal · doi:10.1378/chest.119.3.726 · Cited by 95
Depression and anxiety in elderly patients with chronic obstructive pulmonary disease
Yohannes, A. M., Baldwin, R., & Connolly, M. J. (2006) · Age and Ageing · doi:10.1093/ageing/afl011 · Cited by 94
Murphy, T. F. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224815.89363.15 · Cited by 92
Carpagnano, G. E., Resta, O., Barbaro, M. P. F., Spanevello, A., Stefano, A., Gioia, G. D., Serviddio, G., & Gramiccioni, E. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.007 · Cited by 90
Miravitlles, M., Ferrer, M., Pont, À., Viejo, J. L., Masa, J. F., Gabriel, R., Jimenez-Ruiz, C. A., Villasante, C., Fernández-Fau, L., & Sobradillo, V. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.01.012 · Cited by 88
Adenoviral E1A primes alveolar epithelial cells to PM10-induced transcription of interleukin-8
Gilmour, P. S., Rahman, I., Hayashi, S., Hogg, J. C., Donaldson, K., & MacNee, W. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.3.l598 · Cited by 82
Synergistic activation of NF-κB by nontypeable Haemophilus influenzae and tumor necrosis factor α
Watanabe, T., Jono, H., Han, J., LIM, D. J., & Li, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400557101 · Cited by 76
Tsoumakidou, M., Tzanakis, Ν., Chrysofakis, G., & Siafakas, N. M. (2005) · CHEST Journal · doi:10.1378/chest.127.6.1911 · Cited by 76
Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor
Widdowson, K. L., Elliott, J. D., Veber, D. F., Nie, H., Rutledge, M. C., McCleland, B. W., Xiang, J., Jurewicz, A. J., Hertzberg, R., Foley, J. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034248l · Cited by 75
Toll-like receptors and chronic lung disease
Chaudhuri, N., Dower, S., Whyte, M. K. B., & Sabroe, I. (2005) · Clinical Science · doi:10.1042/cs20050044 · Cited by 75
Effects of exacerbations and seasonality on exhaled nitric oxide in COPD
Bhowmik, A., Seemungal, T. A. R., Donaldson, G. C., & Wedzicha, J. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00047305 · Cited by 71
Zhu, J., MAJUMDAR, S., Qiu, Y., Ansari, T. W., Oliva, A., KIPS, J. C., PAUWELS, R. A., Rose, V. D., & Jeffery, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.12.2009060 · Cited by 70
Hadida, F., Vieillard, V., Mollet, L., Clark‐Lewis, I., Baggiolini, M., & Debré, P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1105 · Cited by 61
Appleton, S., Poole, P., Smith, B. J., Cates, C. J., Veale, A., & Bara, A. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001104 · Cited by 48
The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E. (2002) · American Journal of Respiratory Medicine · doi:10.1007/bf03256615 · Cited by 42
Rennard, S. I., Schachter, N. S., Strek, M. E., RICKARD, K. A., & Amit, O. (2006) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2006.03.037 · Cited by 29
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationImmunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationThe Empirical Foundations of Telemedicine Interventions for Chronic Disease Management
Bashshur, R. L., Shannon, G. W., Smith, B. R., Alverson, D. C., Antoniotti, N., Barsan, W. G., Bashshur, N., Brown, E. M., Coye, M. J., Doarn, C. R., et al. (2014) · Telemedicine and e-Health · doi:10.1089/tmj.2014.9981 · Cited by 452
Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
Thomsen, M., Ingebrigtsen, T. S., Marott, J. L., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2013) · JAMA · doi:10.1001/jama.2013.5732 · Cited by 401
Celli, B. R., Fabbri, L. M., Aaron, S. D., Agusti, A., Brook, R., Criner, G. J., Franssen, F. M. E., Humbert, M., Hurst, J. R., O’Donnell, D., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1819pp · Cited by 371
Self-citation
Metadata
- Authors
- Celli, B. R., & Barnes, P. J.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-05-31
- Volume
- 29
- Issue
- 6
- Pages
- 1224-1238
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2125522165
- Cited by
- 462
- References
- 149
- FWCI
- 25.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.